Novavax (NVAX) Return on Capital Employed Growth (3y) (2015 - 2026)
Novavax (NVAX) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
-643,209.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-643,209.00 |
| Dec 31, 2025 |
-26,443.00 |
| Sep 30, 2025 |
19,483.00 |
| Jun 30, 2025 |
28,344.00 |
| Mar 31, 2025 |
32,617.00 |
| Dec 31, 2024 |
88,002.00 |
| Sep 30, 2024 |
6,393.00 |
| Jun 30, 2024 |
2,222.00 |
| Mar 31, 2024 |
1,624.00 |
| Dec 31, 2023 |
-55,357.00 |
| Sep 30, 2023 |
-27,195.00 |
| Jun 30, 2023 |
-354,653.00 |
| Mar 31, 2023 |
646,650.00 |
| Dec 31, 2022 |
41,174.00 |
| Sep 30, 2022 |
-6,873.00 |
| Jun 30, 2022 |
-14,459.00 |
| Mar 31, 2022 |
-19,205.00 |
| Dec 31, 2021 |
-83,699.00 |
| Sep 30, 2021 |
-3,637.00 |
| Jun 30, 2021 |
-1,712.00 |
